Unreliable immunoassays, patients' safety, and clinical research

Slides:

Advertisements

Similar presentations

What We Talk About When We Talk About Fat Evan D. Rosen, Bruce M. Spiegelman Cell Volume 156, Issue 1, Pages (January 2014) DOI: /j.cell

Advertisements

Two views of brain function Marcus E. Raichle Trends in Cognitive Sciences Volume 14, Issue 4, Pages (April 2010) DOI: /j.tics

Healthy clocks, healthy body, healthy mind Akhilesh B. Reddy, John S. O’Neill Trends in Cell Biology Volume 20, Issue 1, Pages (January 2010) DOI:

Crohn's disease Prof Daniel C Baumgart, MD, Prof William J Sandborn, MD The Lancet Volume 380, Issue 9853, Pages (November 2012) DOI: /S (12)

Redefining vitamin D insufficiency

Pharmacogenetics and future drug development and delivery

Dizziness in older adults

Thank God for Richard Dawkins?

Long-term effects of hormone replacement therapy

Antioxidants and pre-eclampsia

Mental illness and mental health

Punishment beatings and the rule of law

Abdominal lipohypertrophy without insulin injection

Author gender in The Lancet journals

Building neurological services in Africa

Physical activity and prevention of type 2 diabetes

Long-term effects of hormone replacement therapy

Pralidoxime for organophosphate poisoning

Political factors behind US global AIDS programmes slow-down

Charity begins at home in global health research funding

Aspirin in the prevention of cancer – Author's reply

Do air quality alerts benefit public health? New evidence from Canada

Coeliac disease The Lancet

Trends in virological and clinical outcomes in individuals with HIV-1 infection and virological failure of drugs from three antiretroviral drug classes:

Non-uraemic calciphylaxis with acral necrosis

Volume 382, Issue 9906, Pages (November 2013)

Physiological hazards of flight at high altitude

Punishment beatings and the rule of law

A next-generation Alzheimer's centre for Madrid

Organisation of the care of patients with heart failure

Disease and stigma The Lancet Volume 354, (December 1999)

Incident diabetes in clinical trials of antihypertensive drugs

Allergen exposure and asthma

HIV myths should not be resuscitated

Pharmacogenetic testing in the UK clinical setting

Pesticide self-poisoning: thinking outside the box

Crime, confidentiality, and clinical judgment

Michael J Goldacre, Jenny J Maisonneuve The Lancet

General Practice Research Database for prescribing analysis

DEPARTMENT OF ERROR The Lancet Volume 362, Issue 9385, (August 2003)

Effect of development assistance on domestic health expenditures

Psychological response and survival in breast cancer

Volume 362, Pages s6-s7 (December 2003)

Blue–black eyes and legs

What would happen if we stopped vaccination?

Volume 152, Issue 1, (January 2013)

Confessions of a journal junkie

Telling it like it isn't: truth and lies in a post-9/11 world

C-reactive protein concentration and the vascular benefits of statin therapy: an analysis of 20 536 patients in the Heart Protection Study Heart Protection.

Thank God for Richard Dawkins?

Department of Error The Lancet Volume 369, Issue 9564, (March 2007)

Low-technology approaches

Diagnosis of tuberculous meningitis with invasive pulmonary sampling

Thank you to our diverse (but not diverse enough) reviewers

Prescription for change

Sunku H Guptha, Eric Holroyd, Gordon Campbell

Costs of eliminating HIV in South Africa have been underestimated

Stem cell transplantation

Cholesterol and all-cause mortality in Honolulu

A remarkable report card on progress in COPD

Difficulties of surgery in the developing world: a personal view

Political factors behind US global AIDS programmes slow-down

Improving management of neonatal infections

Volume 1, Issue 2, Pages (July 2014)

Tapestry of life The Lancet Volume 375, Issue 9723, (April 2010)

Living in colour—American children, race, and wellbeing

Volume 349, Issue 9062, Pages (May 1997)

The dilemma of vaginal breech delivery worldwide

Autism, maths, and sex: the special triangle

Volume 148, Issue 1, (January 2012)

Presentation transcript:

Unreliable immunoassays, patients' safety, and clinical research Göran Lindstedt, Sofia Frändberg The Lancet Volume 359, Issue 9303, (January 2002) DOI: 10.1016/S0140-6736(02)07516-5 Copyright © 2002 Elsevier Ltd Terms and Conditions

Figure Relation between values for serum tri-iodothyronine concentration measured by two immunoassay methods Abbott Architect values <0·60 nmol/L reassayed with Abbott AxSym. Values <0·38 nmol/L obtained with Abbott Architect are reported as 0·38 nmol/L. The Lancet 2002 359, DOI: (10.1016/S0140-6736(02)07516-5) Copyright © 2002 Elsevier Ltd Terms and Conditions